AR and breast carcinoma: While AR and anti-AR drugs are important and relatively new areas of breast cancer research[87-90], the vitamin D3 receptor[91,92], glucocorticoid receptor[93,94], retinoic acid receptor alpha[95,96], and other NR are less well explored in the pathogenesis of this disease.